Royalty Pharma plc
RPRX
株式のランク
#860
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
株価
$62.20
最終同期: 2026-10-21
時価総額
$27.69B
変化（1日）
-0.09%
変化（1年）
68.82%
国
US
取引 Royalty Pharma plc (RPRX)
カテゴリー
Healthcare
Royalty Pharma plc（RPRX）の株価履歴
終値の最高値: $58.43 （2026-10-01）
終値の最安値: $49.50 （2020-06-01）
終値の最安値: $49.50 （2020-06-01）
Royalty Pharma plc の株価履歴（2020 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | 27.24% |
| 2025 | 52.96% |
| 2024 | -9.35% |
| 2023 | -31.53% |
| 2022 | 5.51% |
| 2021 | -14.39% |
| 2020 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $45.44 | 35.30% |
SE
|
|
| $171.37 | 23.91% |
FR
|
|
| $116.39 | 58.03% |
US
|
|
| $59.52 | -0.48% |
IT
|
|
| $0.63 | -31.50% |
HK
|
